AD patients exhibit deposition of β-amyloid plaques and neurofibrillary tangles in the brain tissue, as well as hyperphosphorylation and aggregation of the Tau protein, which is the main actor in disease progression. This evidence concerns the gene MAPT and Alzheimer disease.